← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:2130 | 2130 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2131 | 2131 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6290 | 71266-6290-1 | Lidocaine, Epinephrine, Tetracaine | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2131 | 2131 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2132 | 2132 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-164 | 63037-164-25 | Lidocaine HCl | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2132 | 2132 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2041 | 71286-2041-2 | Morphine Sulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2133 | 2133 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-051 | 70713-051-01 | ESTRADIOL 12.5MG | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2133 | 2133 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2008 | 71286-2008-1 | Morphine Sulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2134 | 2134 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-255 | 70092-255-75 | Fent 2mcg/mL-Bup 0.1%PF100mlNS CADDYFSFF | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2134 | 2134 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2040 | 71286-2040-5 | Morphine Sulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2135 | 2135 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2539 | 72934-2539-4 | Nobela | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2135 | 2135 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2040 | 71286-2040-3 | Morphine Sulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2136 | 2136 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6510 | 72934-6510-2 | Mekam | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2136 | 2136 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-979 | 69374-979-02 | Morphine Sulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2137 | 2137 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2406 | 72627-2406-1 | Alpha-Lipoic Acid | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2137 | 2137 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2138 | 2138 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0422 | 72196-0422-1 | Trophamine 4% / Dextrose 10% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2138 | 2138 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2139 | 2139 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2001 | 71266-2001-3 | Succinylcholine Chloride | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2139 | 2139 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2140 | 2140 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5473 | 26436-5473-1 | BLT Topical Gel | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2140 | 2140 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2141 | 2141 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2001 | 71266-2001-8 | Succinylcholine Chloride | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2141 | 2141 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-9007 | 26436-9007-2 | Morphine Sulfate; Bupivacaine Hydrochloride Related Compound A | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2142 | 2142 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6610 | 71300-6610-3 | NALTREXONE HYDROCHLORIDE | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2142 | 2142 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-9007 | 26436-9007-4 | Morphine Sulfate; Bupivacaine Hydrochloride Related Compound A | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2143 | 2143 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4348 | 72934-4348-8 | Tetpidtar Solution | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2143 | 2143 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-9022 | 26436-9022-2 | Morphine Sulfate; Bupivacaine Hydrochloride Related Compound A | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2144 | 2144 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6641 | 71266-6641-1 | Sodium Citrate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2144 | 2144 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1050 | 5446-1050-01 | Moxifloxacin | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2145 | 2145 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3037 | 79559-3037-1 | S-E037.5 | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2145 | 2145 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2146 | 2146 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5473 | 26436-5473-3 | BLT Topical Gel | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2146 | 2146 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-097 | 71449-097-42 | Moxifloxacin Hydrochloride | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2147 | 2147 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-031 | 71506-031-51 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2147 | 2147 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8602 | 71266-8602-1 | Moxifloxacin Hydrochloride | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2148 | 2148 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2001 | 71266-2001-2 | Succinylcholine Chloride | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2148 | 2148 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8603 | 71266-8603-1 | Moxifloxacin Hydrochloride | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2149 | 2149 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5002 | 26436-5002-1 | B6-Fusion | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2149 | 2149 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2150 | 2150 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6610 | 71300-6610-3 | NALTREXONE HYDROCHLORIDE | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2150 | 2150 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2151 | 2151 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-175 | 70092-175-46 | Lidocaine 1% Bicarb 10 ml syr PF | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2151 | 2151 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70360-077 | 70360-077-35 | Moxifloxacin Hydrochloride | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2152 | 2152 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5024 | 26436-5024-3 | Taurine 50mg/mL | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2152 | 2152 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70360-003 | 70360-003-35 | Moxifloxacin Hydrochloride | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2153 | 2153 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-373 | 73693-373-01 | ESTRADIOL 10MG | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2153 | 2153 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2154 | 2154 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0022 | 73271-0022-1 | ESTRADIOL 22 PEL | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2154 | 2154 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2155 | 2155 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-984 | 69374-984-10 | del Nido Cardioplegia | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2155 | 2155 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2156 | 2156 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70657-1027 | 70657-1027-5 | Semaglutide | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2156 | 2156 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2157 | 2157 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-519 | 70092-519-48 | Morphine PF 1 mg/ml in 30 ml NS syr | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2157 | 2157 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2158 | 2158 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-145 | 82396-145-25 | Lorazepam | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2158 | 2158 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride; Triamcinolone Acetonide | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2159 | 2159 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-5002 | 70168-5002-1 | Estradiol 12.5mg | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2159 | 2159 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0605 | 5446-0605-01 | Mupirocin; Clotrimazole; Betamethasone Acetate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2160 | 2160 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5200 | 26436-5200-6 | BLT | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2160 | 2160 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nafcillin Sodium | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2161 | 2161 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8012 | 72682-8012-1 | Testosterone 12.5mg Pellet | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2161 | 2161 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69623-235 | 69623-235-39 | Naloxone Hydrochloride Dihydrate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2162 | 2162 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-509 | 70092-509-35 | Fentanyl PF 50 mcg/ml 50ml IVB | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2162 | 2162 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Naltrexone | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2163 | 2163 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5083 | 71266-5083-1 | Vancomycin 1.25g/250mL | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2163 | 2163 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Naltrexone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2164 | 2164 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-069 | 71449-069-11 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2164 | 2164 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Naltrexone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2165 | 2165 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0432 | 71285-0432-1 | Trophamine 4.5%/Dextrose 10% With Heparin 125 units 250ml in 250ml bag | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2165 | 2165 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Naltrexone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2166 | 2166 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6523 | 72934-6523-2 | Mavilo | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2166 | 2166 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Naltrexone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2167 | 2167 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8069 | 71285-8069-1 | Oxytocin 40units added to NS | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2167 | 2167 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Naltrexone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2168 | 2168 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-035 | 71506-035-56 | Acyclovir Sodium | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2168 | 2168 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Naltrexone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2169 | 2169 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8100 | 72682-8100-1 | Testosterone 100mg Pellet | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2169 | 2169 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Naltrexone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2170 | 2170 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-002 | 81375-002-05 | Prednisolone/Bromfenac | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2170 | 2170 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Naltrexone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2171 | 2171 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-145 | 82396-145-13 | Lorazepam | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2171 | 2171 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Naltrexone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2172 | 2172 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3025 | 79559-3025-1 | S-E025 | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2172 | 2172 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Naltrexone Hydrochloride; Clobetasol Propionate; Zinc Sulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2173 | 2173 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-125 | 71449-125-11 | Neostigmine Methylsulfate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2173 | 2173 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nandrolone Decanoate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2174 | 2174 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9115 | 71266-9115-1 | Hydromorphone HCl | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2174 | 2174 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2107 | 72627-2107-3 | Nandrolone Decanoate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2175 | 2175 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5040 | 71266-5040-1 | Fentanyl | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2175 | 2175 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5022 | 26436-5022-1 | Nandrolone Decanoate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2176 | 2176 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-8101 | 70168-8101-1 | Testosterone 25mg | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2176 | 2176 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0241 | 71283-0241-5 | Nandrolone Decanoate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2177 | 2177 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0054 | 81483-0054-4 | Tirzepatide | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2177 | 2177 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neomycin Sulfate; Polymyxin B Sulfate; Dexamethasone | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2178 | 2178 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2050 | 70168-2050-1 | E2 18mg | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2178 | 2178 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0894 | 5446-0894-01 | Neostigmine Methylsulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2179 | 2179 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-3712 | 72682-3712-1 | Estradiol 12.5mg | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2179 | 2179 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2180 | 2180 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2324 | 72627-2324-7 | Tirzepatide/Niacinamide | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2180 | 2180 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2181 | 2181 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2304 | 72934-2304-2 | Varoxia Cream | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2181 | 2181 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-750 | 70004-750-25 | Neostigmine Methylsulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2182 | 2182 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-372 | 69761-372-01 | Testosterone / Stearic Acid | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2182 | 2182 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-750 | 70004-750-09 | Neostigmine Methylsulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2183 | 2183 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-203 | 73702-203-02 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2183 | 2183 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2184 | 2184 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2115 | 72907-2115-5 | Methylprednisolone Acetate | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2184 | 2184 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2185 | 2185 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0000 | 81483-0000-0 | LIDOCAINE | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2185 | 2185 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3328 | 62295-3328-5 | Neostigmine Methylsulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2186 | 2186 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-691 | 69852-691-10 | Triamcinolone Acetonide 50 mg/mL | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2186 | 2186 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2187 | 2187 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2323 | 72627-2323-6 | Tirzepatide/Niacinamide | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2187 | 2187 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9020 | 71266-9020-5 | Neostigmine Methylsulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2188 | 2188 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-006 | 73198-006-03 | FA | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2188 | 2188 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9020 | 71266-9020-3 | Neostigmine Methylsulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2189 | 2189 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1226 | 73271-1226-2 | TESTOSTERONE CYPIONATE 200 MG/ML MIGLYOL 812N 30ML NDC 73271-1226-2 | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2189 | 2189 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-1 | Neostigmine Methylsulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2190 | 2190 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5170 | 71266-5170-1 | Phenylephrine HCl | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2190 | 2190 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-2 | Neostigmine Methylsulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2191 | 2191 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-1200 | 79559-1200-1 | S-T200 | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2191 | 2191 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0749 | 5446-0749-10 | Neostigmine Methylsulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2192 | 2192 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0020 | 70168-0020-1 | Testo25mg | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2192 | 2192 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2193 | 2193 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-203 | 73702-203-65 | Fentanyl Citrate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2193 | 2193 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2194 | 2194 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0425 | 71285-0425-1 | Trophamine 2% / Dextrose 10% With Calcium Gluconate 2.33mEq and Heparin 125 units 250ml in 250ml bag | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2194 | 2194 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2195 | 2195 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-173 | 63037-173-25 | Phenylephrine HCl | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2195 | 2195 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2196 | 2196 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-873 | 69761-873-01 | Testosterone | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2196 | 2196 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2197 | 2197 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2321 | 72627-2321-5 | Semaglutide/Cyanocobalamin | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2197 | 2197 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2198 | 2198 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-872 | 69761-872-01 | Testosterone / Stearic Acid | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2198 | 2198 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2199 | 2199 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-6023 | 26436-6023-3 | TESTOSTERONE 15% | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2199 | 2199 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2200 | 2200 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8264 | 72682-8264-1 | Testosterone 60mg/Anastrozole 4mg Pellet | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2200 | 2200 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2201 | 2201 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-9005 | 72196-9005-1 | del Nido Isolyte-S | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2201 | 2201 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2202 | 2202 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-116 | 70092-116-75 | Hydromorph PF0.2 mg/ml 100ml NS CADDFSFF | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2202 | 2202 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2203 | 2203 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5000 | 71266-5000-1 | Oxytocin | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2203 | 2203 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2204 | 2204 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8221 | 71266-8221-1 | Tropicamide 1%, Cyclopentolate 1%, Phenylephrine 2.5%, Ketorolac 0.4%, Proparacaine 0.1% | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2204 | 2204 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2205 | 2205 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-155 | 63037-155-25 | Rocuronium Bromide | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2205 | 2205 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2206 | 2206 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9012 | 83826-9012-3 | Atropine Sulfate Monohydrate | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2206 | 2206 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2207 | 2207 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2568 | 72934-2568-2 | Aluris | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2207 | 2207 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2208 | 2208 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-003 | 70713-003-01 | TESTOSTERONE C 100MG | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2208 | 2208 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-922 | 69374-922-03 | Neostigmine Methylsulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2209 | 2209 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2589 | 72934-2589-2 | Awanis | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2209 | 2209 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-942 | 69374-942-04 | Neostigmine Methylsulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2210 | 2210 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5050 | 71266-5050-1 | Fentanyl | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2210 | 2210 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-932 | 69374-932-03 | Neostigmine Methylsulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2211 | 2211 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0421 | 72196-0421-1 | Trophamine 3.5%/Dextrose 10% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2211 | 2211 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-932 | 69374-932-33 | Neostigmine Methylsulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2212 | 2212 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6073 | 72196-6073-1 | Vancomycin 1.25gm added to D5W | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2212 | 2212 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-902 | 69374-902-05 | Neostigmine Methylsulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2213 | 2213 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-30 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2213 | 2213 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2214 | 2214 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-053 | 70092-053-05 | Vancomycin PF 1 g add to 250 ml NS bag | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2214 | 2214 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6065 | 71286-6065-1 | Neostigmine Methylsulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2215 | 2215 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-079 | 71506-079-56 | Thiamine Hydrochloride | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2215 | 2215 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6065 | 71286-6065-3 | Neostigmine Methylsulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2216 | 2216 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-03 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2216 | 2216 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2217 | 2217 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73217-005 | 73217-005-10 | Tacrolimus 1% Ophth | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2217 | 2217 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2218 | 2218 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2576 | 72934-2576-2 | Alvox | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2218 | 2218 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2219 | 2219 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-776 | 69852-776-10 | Dexamethasone Acetate 8 mg/mL | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2219 | 2219 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2220 | 2220 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2562 | 72934-2562-2 | Avidora | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2220 | 2220 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2221 | 2221 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6007 | 72196-6007-1 | Phenylephrine 40mcg/ml in NS | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2221 | 2221 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2222 | 2222 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5457 | 26436-5457-1 | TESTOSTERONE 25mg | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2222 | 2222 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0329 | 60652-0329-1 | Neostigmine Methylsulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2223 | 2223 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0010 | 73271-0010-1 | ESTRADIOL 10 PEL | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2223 | 2223 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2224 | 2224 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-01 | Hydromorphone Hydrochloride | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2224 | 2224 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2225 | 2225 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-3725 | 72682-3725-1 | Estradiol 25mg | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2225 | 2225 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-008 | 71449-008-10 | Neostigmine Methylsulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2226 | 2226 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1399 | 72934-1399-2 | Dazaveidaoxia | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2226 | 2226 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-008 | 71449-008-11 | Neostigmine Methylsulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2227 | 2227 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-950 | 71170-950-25 | Fentanyl 500mcg and Ropivacaine HCl 250mg added to 250mL Normal Saline | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2227 | 2227 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69623-234 | 69623-234-15 | Neostigmine Methylsulfate | 2019-1 | valid | 0 | 2026-10-24 | |
compounder:2228 | 2228 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-873 | 69761-873-01 | Testosterone | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2228 | 2228 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2229 | 2229 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6646 | 71300-6646-3 | Naltrexone HCl | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:2229 | 2229 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2019-1 | source_no_ndc | 1 | 2026-10-24 | |||
compounder:2230 | 2230 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-005 | 73198-005-03 | T-105 | 2026-1 | valid | 0 | 2026-09-18 |